Diagnostic Challenge in Diagnosing Atypical Pityriasis Rosea: A Case Report [PDF]
Case Reports in DermatologyIntroduction Pityriasis rosea is a self-limited inflammatory skin condition most commonly associated with systemic active viral infection, particularly human herpesvirus (HHV)-6 and HHV-7.
Madeline N. Pham +2 more
doaj +3 more sources
Manifestation of pityriasis rosea and pityriasis rosea‐like eruptions after Covid‐19 vaccine: A systematic review [PDF]
Immunity, Inflammation and Disease, 2023 Background: After introducing Covid‐19 vaccines, a few side effects were reported, pityriasis rosea being one of them. Therefore, this study will systematically review its manifestation afteradministration.Methods: Databases were searched, covering a ...
Iman Khan +5 more
doaj +3 more sources
Recurrent Pityriasis Rosea: A Case Report
Human Vaccines and Immunotherapeutics, 2018 Pityriasis rosea is a papulosquamous skin disorder that occurs most commonly between the ages of 10 and 35 years. Recurrent pityriasis rosea is rare. We report a patient suffering from recurrent pityriasis rosea, whose etiology may be related to either ...
Ang Li, Ping Li, Yanqiong Li, Wenfei Li
exaly +3 more sources
An Atypical Case of Pityriasis Rosea Gigantea After Influenza Vaccination
Case Reports in Dermatology, 2014 Pityriasis rosea is a common erythematosquamous eruption, typically presenting along the cleavage lines of the skin. A wide spectrum of atypical manifestations may challenge even the most experienced physician.
Dimitrios Papakostas +2 more
exaly +6 more sources
A Case of Persistent Pityriasis Rosea Successfully Treated by a Short Course of Therapy with Abrocitinib [PDF]
Clinical, Cosmetic and Investigational DermatologyHao Wu, Qing-Jie Ji, Yu-Yang Xu, Jian-Wei Zhu Department of Dermatology, Quzhou TCM Hospital at the Junction of Four Provinces Affiliated to Zhejiang Chinese Medical University, Quzhou, People’s Republic of ChinaCorrespondence: Jian-Wei Zhu, Email zjwmed@
Wu H, Ji QJ, Xu YY, Zhu JW
doaj +4 more sources
Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review [PDF]
Clinical, Cosmetic and Investigational DermatologyLuca Potestio,* Fabrizio Martora,* Sara Cacciapuoti, Matteo Megna, Alessia Villani, Angelo Ruggiero Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy*These authors ...
Alessia Villani +2 more
exaly +4 more sources
Pityriasis Rosea and Pityriasis Rosea-like Eruption Following COVID-19 Vaccinations: Case Series from Oman [PDF]
Oman Medical Journal, 2023 To mitigate the impact of the COVID-19 pandemic, several vaccines have been developed and administered to the public since 2021. A spectrum of cutaneous reactions has been reported among some of the vaccinated individuals.
Iman Al Hatmi +4 more
doaj +2 more sources
Domperidone‐induced pityriasis rosea‐like drug eruption [PDF]
Clinical Case Reports, 2022 Pityriasis rosea is a common, acute, self limiting inflammatory skin disease. Pityriasis rosea‐like eruptions (PR‐LE) have been reported after drugs. The clinical presentation of PR‐LE can be distinguished from pityriasis rosea.
Sarra Saad +3 more
doaj +2 more sources
Pityriasis Rosea Recurrence Is Much Higher Than Previously Known: A Prospective Study
Acta Dermato-Venereologica, 2019 Pityriasis rosea is a common acute exanthema of unknown aetiology, which causes severe anxiety. In this study, the demographic data of pityriasis rosea patients, who presented to our clinic between 2013 and 2017, were prospectively recorded. The patients
Maviş Yüksel
exaly +2 more sources
Dupilumab-induced pityriasis rosea [PDF]
JAAD Case Reports, 2023 Morgan Zabel, BS +5 more
doaj +2 more sources